Abstract:Introduction: Hirschsprung disease (HD) manifests as a developmental anomaly affecting the enteric nervous system, where there is an absence of ganglion cells in the lower part of the intestine. This deficiency leads to functional blockages within the intestines. HD is usually confirmed or ruled out through rectal biopsy. The identification of any ganglion cells through hematoxylin and eosin (H&E) staining rules out HD. If ganglion cells are absent, further staining with acetylcholine-esterase (AChE) histochemistry or calretinin immunohistochemistry (IHC) forms part of the standard procedure for determining a diagnosis of HD. In 2017, our Institute of Pathology at University Hospital of Heidelberg changed our HD diagnostic procedure from AChE histochemistry to calretinin IHC. In this paper, we report the impact of the diagnostic procedure change on surgical HD therapy procedures and on the clinical outcome of HD patients. Methods: We conducted a retrospective review of the diagnostic procedures, clinical data, and postoperative progress of 29 patients who underwent surgical treatment for HD in the Department of Pediatric Surgery, University of Heidelberg, between 2012 and 2021. The patient sample was divided into two groups, each covering a treatment period of 5 years. In 2012–2016, HD diagnosis was performed exclusively using AChE histochemistry (AChE group, n = 17). In 2017–2021, HD diagnosis was performed exclusively using calretinin IHC (CR group, n = 12). Results: There were no significant differences between the groups in sex distribution, weeks of gestation, birth weight, length of the aganglionic segment, or associated congenital anomalies. Almost half of the children in the AChE group, twice as many as in the CR group, required an enterostomy before transanal endorectal pull-through procedure (TERPT). In the AChE group, 4 patients (23.5%) required repeat bowel sampling to confirm the diagnosis. Compared to the AChE group, more children in the CR group suffered from constipation post TERPT. Discussion: Elevated AChE expression is linked to hypertrophied extrinsic cholinergic nerve fibers in the aganglionic segment in the majority of patients with HD. The manifestation of increased AChE expression develops over time. Therefore, in neonatal patients with HD, especially those in the first 3 weeks of life, an increase in AChE reaction is not detected. Calretinin IHC reliably identifies the presence or absence of ganglion cells and offers multiple benefits over AChE histochemistry. These include the ability to perform the test on paraffin-embedded tissue sections, a straightforward staining pattern, a clear binary interpretation (negative or positive), cost-effectiveness, and utility regardless of patient age. Conclusions: The ability of calretinin IHC to diagnose HD early and time-independently prevented repeated intestinal biopsies in our patient population and allowed us to perform a one-stage TERPT in the first months of life, reducing the number of enterostomies and restoring colonic continuity early. Patients undergoing transanal pull-through under the age of 3 months require a close follow-up to detect cases with bowel movement problems.

Evaluation of Calretinin and AchE in pathological diagnosis for rectal mucosa biopsy of neonatal Hirschsprung's disease

[Evaluation of Clinical Value of Anorectal Manometry for Diagnosis of Hirschsprung's Disease in Neonate].

Clinical Evaluation of Diagnostic Methods for Hirschsprung's Disease

Clinical Relevance of Pathological Diagnosis of Hirschsprung’s Disease with Acetylcholine-Esterase Histochemistry or Calretinin Immunohistochemistry

Expression characteristics of calretinin in hirschsprung′s disease and its clinical significance

The Diagnostic Value of Immunohistochemistry Markers in Hirschsprung Disease; A Systematic Review and Meta-analysis

Clinical Evaluation of Laparoscopic Surgery for Hirschsprung Disease Combined with Colorectal Anastomosis with a Stapling Technique in Infants.

The Evaluation of Acid Reflux Index in the Diagnosis of Pathological Gastroesophageal Reflux in Children: the Analysis of Data of Esophageal Ph Monitoring of 4109 Cases in 12 Years

Is hematoxylin-eosin staining in rectal mucosal and submucosal biopsies still useful for the diagnosis of Hirschsprung disease?

The Application of Immunohistochemistry in the Diagnosis of Hirschsprung's Disease and Allied Diseases

Differential Expressions of BMPR1α, ACTN4α and FABP7 in Hirschsprung Disease.

Postoperative Acetylcholinesterase Activity in Hirschsprung's Disease

Abnormal development of circular muscles in aganglionic segments of HSCR patients

Management of Hirschsprung's disease in mainland China

Chinese expert consensus statement on the diagnosis and treatment of Hirschsprung disease

Expression Analysis of Bmp2, Bmp5, Bmp10 in Human Colon Tissues from Hirschsprung Disease Patients

Expression of Dishevelled Gene in Hirschsprung's Disease.

Guidance of a pathological grading system of ganglion cells for intraoperative rapid biopsy of Hirschsprung disease for determining surgical margin and predicting bowel function

Serum Metabolomic Signatures of Hirschsprung's Disease Based on GC-MS and LC-MS

Rectal biopsies for Hirschsprung disease: Patient characteristics by diagnosis and attending specialty

The Single Nucleotide Polymorphisms in Smad-interacting Protein 1 Gene Contribute to Its Ectopic Expression and Susceptibility in Hirschsprung's Disease.